FDA Approved: MONTELUKAST — Original Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved Montelukast from BluePoint Laboratories under an Original Application (ANDA), granting generic montelukast access for approved indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Exercise-induced Bronchoconstriction
• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• Montelukast (Montelukast)

Snippet

ORIG AP for MONTELUKAST (MONTELUKAST)